Award recordCONTRACT

KREMERS URBAN PHARMACEUTICALS INC.

PIID 36E79720N0017· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $583,106 net obligations· UEI UW6UVG3T5LX6· IN

Description

DECREASE OBLIGATION ON AN ESTIMATED BULK DELIVERY ORDER OF OMEPRAZOLE FOR THE PHARM REPACKAGING PROGRAM.

Base award description: BULK DELIVERY ORDERS OF OMEPRAZOLE FOR THE PHARM REPACKAGING PROGRAM.

First action · last action
2020-03-03 · 2020-06-10
Transactions
2
First transaction's obligation
$583,800
Base + all options value (sum of deltas)
$583,106
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0359
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$583,800$0Base award · 2020-03-03 · this action $583,800 · running total $583,800Modification P00001 · 2020-06-10 · this action -$694 · running total $583,106
  • Base2020-03-03+$583,800= $583,800
  • Mod P000012020-06-10-$694= $583,106
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-03-03+$583,800$583,800BULK DELIVERY ORDERS OF OMEPRAZOLE FOR THE PHARM REPACKAGING PROGRAM.
Mod P00001· FUNDING ONLY ACTION2020-06-10−$694$583,106DECREASE OBLIGATION ON AN ESTIMATED BULK DELIVERY ORDER OF OMEPRAZOLE FOR THE PHARM REPACKAGING PROGRAM.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UW6UVG3T5LX6)

AwardOffice · PSC / listingNet obligationsFY
36E79720N0014NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$845,319FY2020
36E79720N0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$669,466FY2020
36E79720N0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$374,423FY2020
36E79720N0006NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$277,856FY2020
36E79720N0002NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$393,081FY2020
36E79719N0047NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$395,087FY2019

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36E79720N0017_3600_36F79718D0359_3600 · retrieved 2026-09-26.